Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care Trades Lower After 2Q Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/30/2019 | 05:38am EDT

By Kim Richters

Shares in Fresenius Medical Care AG fell on Tuesday, after the health-care company reported a fall in second-quarter profit.

The company, which is the dialysis division of Fresenius SE & Co. KGaA (FRE.XE), reported second-quarter sales of 4.28 billion euros ($4.76 billion), compared with EUR3.96 billion the previous year, and said its net income for the quarter was EUR279 million, down from EUR308 million.

The company's sales, net income and earnings before interest and taxes were below expectations, analysts at UBS said.

At 0915 GMT, shares in Fresenius Medical Care traded 5.64% lower at EUR63.60.

"Investors are likely to focus on the headline miss driven by care coordination and international," UBS said.

Write to Kim Richters at kim.richters@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
E.ON SE -0.34% 8.993 Delayed Quote.4.53%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.76% 62.58 Delayed Quote.11.26%
FRESENIUS SE & CO. KGAA -1.35% 43.71 Delayed Quote.4.64%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
09/19FRESENIUS MEDICAL CARE : Launches 4008A™ Dialysis Machine in China
BU
09/16FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
09/15Fresenius drops possible sale of blood transfusion unit - spokesman
RE
09/10FRESENIUS6CPRF : Fresenius Medical Care's annual medical report explores how Int..
AQ
09/09FRESENIUS MEDICAL CARE : annual medical report explores how Interconnected Intel..
PU
09/09FRESENIUS MEDICAL CARE : Spectra Laboratories - Fresenius Medical Care builds ne..
AQ
09/09FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
09/06FRESENIUS MEDICAL CARE : Builds New Laboratory in US
DJ
09/05Fresenius Medical Care to Invest in Its Stem-Cell Subsidiary Unicyte
DJ
09/03Fresenius Helios Acquires Two Hospitals in Colombia
DJ
More news
Financials (USD)
Sales 2019 19 393 M
EBIT 2019 2 592 M
Net income 2019 1 318 M
Debt 2019 9 019 M
Yield 2019 1,84%
P/E ratio 2019 16,0x
P/E ratio 2020 13,6x
EV / Sales2019 1,56x
EV / Sales2020 1,45x
Capitalization 21 148 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 87,26  $
Last Close Price 69,27  $
Spread / Highest target 59,7%
Spread / Average Target 26,0%
Spread / Lowest Target -29,6%
EPS Revisions
Managers
NameTitle
Rice Powell Chief Executive Officer
Dieter Schenk Chairman-Supervisory Board
Michael Brosnan Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
William P. Johnston Member-Supervisory Board